1. Reitan K. Principles of retention and avoidance of posttreatment relapse. Am J Orthod. 1969. 55:776–790.
Article
2. Edwards JG. A long-term prospective evaluation of the circumferential supracrestal fiberotomy in alleviating orthodontic relapse. Am J Orthod Dentofacial Orthop. 1988. 93:380–387.
Article
3. Proffit WR. Proffit WR, Fields HW, editors. Retention. Contemporary Orthodontics. 2000. 3rd ed. St Louis: Mosby;597–614.
4. Baumrind S. A reconsideration of the propriety of the "pressure-tension" hypothesis. Am J Orthod. 1969. 55:12–22.
Article
5. Davidovitch Z, Finkelson MD, Steigman S, Shanfeld JL, Montgomery PC, Korostoff E. Electric currents, bone remodeling, and orthodontic tooth movement, II. Increase in rate of tooth movement and periodontal cyclic nucleotide levels by combined force and electric current. Am J Orthod. 1980. 77:33–47.
6. Reitan K. Tissue behavior during orthodontic tooth movement. Am J Orthod. 1960. 46:881–900.
Article
7. Reitan K, Kvam E. Comparative behavior of human and animal tissue during experimental tooth movement. Angle Orthod. 1971. 41:1–14.
8. Joondeph DR, Riedel RA. Graber TM, Vanarsdall RL, editors. Retention and Relapse. Orthodontics: Current Principles and Techniques. 1994. St Louis: Mosby-Year Book;908–950.
9. Saito M, Saito S, Ngan PW, Shanfeld J, Davidovitch Z. Interleukin 1 beta and prostaglandin E are involved in the response of periodontal cells to mechanical stress in vivo and in vitro. Am J Orthod Dentofacial Orthop. 1991. 99:226–240.
Article
10. Binderman I, Zor U, Kaye AM, Shimshoni Z, Harell A, Sömjen D. The transduction of mechanical force into biochemical events in bone cells may involve activation of phospholipase A2. Calcif Tissue Int. 1988. 42:261–266.
Article
11. Samuelsson B, Granström E, Green K, Hamberg M, Hammarström S. Prostaglandins. Annu Rev Biochem. 1975. 44:669–695.
Article
12. Norevall LI, Forsgren S, Matsson L. Expression of neuropeptides (CGRP, substance P) during and after orthodontic tooth movement in the rat. Eur J Orthod. 1995. 17:311–325.
Article
13. Alhashimi N, Frithiof L, Brudvik P, Bakhiet M. Orthodontic movement induces high numbers of cells expressing IFN-gamma at mRNA and protein levels. J Interferon Cytokine Res. 2000. 20:7–12.
Article
14. Adachi H, Igarashi K, Mitani H, Shinoda H. Effects of topical administration of a bisphosphonate (risedronate) on orthodontic tooth movements in rats. J Dent Res. 1994. 73:1478–1484.
Article
15. Giunta D, Keller J, Nielsen FF, Melsen B. Influence of indomethacin on bone turnover related to orthodontic tooth movement in miniature pigs. Am J Orthod Dentofacial Orthop. 1995. 108:361–366.
Article
16. Kehoe MJ, Cohen SM, Zarrinnia K, Cowan A. The effect of acetaminophen, ibuprofen, and misoprostol on prostaglandin E2 synthesis and the degree and rat of orthodontic tooth movement. Angle Orthod. 1996. 66:339–349.
17. Wong A, Reynolds EC, West VC. The effect of acetylsalicylic acid on orthodontic tooth movement in the guinea pig. Am J Orthod Dentofacial Orthop. 1992. 102:360–365.
Article
18. Kim TW, Yoshida Y, Yokoya K, Sasaki T. An ultrastructural study of the effects of bisphosphonate administration on osteoclastic bone resorption during relapse of experimentally moved rat molars. Am J Orthod Dentofacial Orthop. 1999. 115:645–653.
Article
19. Igarashi K, Mitani H, Adachi H, Shinoda H. Anchorage and retentive effects of a bisphosphonate (AHBuBP) on tooth movements in rats. Am J Orthod Dentofacial Orthop. 1994. 106:279–289.
Article
20. Clark WG, Brater DC, Johnson AR. Nonsteroidal anti-inflammatory antipyretic analgesics. Goth's Medical Pharmacology. 1992. 13th ed. St Louis: Mosby-Year Book;356–373.
21. Han JW, Kim SH. Effects of bisphosphonates on developing hard tissues of the jaws in rats. J Dent Science. 2001. 13:194–210.
22. Agnusdei D, Bufalino L. Efficacy of ipriflavone in established osteoporosis and long-term safety. Calcif Tissue Int. 1997. 61:Suppl 1. S23–S27.
Article
23. Kovács AB. Efficacy of ipriflavone in the prevention and treatment of postmenopausal osteoporosis. Agents Actions. 1994. 41:86–87.
Article
24. Reginster JY. Ipriflavone: pharmacological properties and usefulness in postmenopausal osteoporosis. Bone Miner. 1993. 23:223–232.
Article
25. Gennari C. Ipriflavone: background. Calcif Tissue Int. 1997. 61:Suppl 1. S3–S4.
Article
26. Civitelli R. In vitro and in vivo effects of ipriflavone on bone formation and bone biomechanics. Calcif Tissue Int. 1997. 61:Suppl 1. S12–S14.
Article
27. Martini M, Formigli L, Tonelli P, Giannelli M, Amunni F, Naldi D, et al. Effects of ipriflavone on perialveolar bone formation. Calcif Tissue Int. 1998. 63:312–319.
Article
28. Notoya K, Tsukuda R, Yoshida K, Taketomi S. Stimulatory effect of ipriflavone on formation of bone-like tissue in rat bone marrow stromal cell culture. Calcif Tissue Int. 1992. 51:Suppl 1. S16–S20.
Article
29. Notoya K, Yoshida K, Tsukuda R, Taketomi S. Effect of ipriflavone on expression of markers characteristic of the osteoblast phenotype in rat bone marrow stromal cell culture. J Bone Miner Res. 1994. 9:395–400.
Article
30. Morita I, Sakaguchi K, Kurachi T, Murota S. Ipriflavone inhibits murine osteoclast formation in vitro. Calcif Tissue Int. 1992. 51:Suppl 1. S7–S10.
31. Benvenuti S, Petilli M, Frediani U, Tanini A, Fiorelli G, Bianchi S, et al. Binding and bioeffects of ipriflavone on a human preosteoclastic cell line. Biochem Biophys Res Commun. 1994. 201:1084–1089.
Article
32. Waldo CM, Rothblatt JM. Histologic response to tooth movement in the laboratory rat; procedure and preliminary observations. J Dent Res. 1954. 33:481–486.
Article
33. Yokoya K, Sasaki T, Shibasaki Y. Distributional changes of osteoclasts and pre-osteoclastic cells in periodontal tissues during experimental tooth movement as revealed by quantitative immunohistochemistry of H(+)-ATPase. J Dent Res. 1997. 76:580–587.
Article
34. Civitelli R, Abbasi-Jarhomi SH, Halstead LR, Dimarogonas A. Ipriflavone improves bone density and biomechanical properties of adult male rat bones. Calcif Tissue Int. 1995. 56:215–219.
Article
35. Cecchini MG, Fleisch H, Mühibauer RC. Ipriflavone inhibits bone resorption in intact and ovariectomized rats. Calcif Tissue Int. 1997. 61:Suppl 1. S9–S11.
Article
36. Perugini P, Genta I, Conti B, Modena T, Pavanetto F. Periodontal delivery of ipriflavone: new chitosan/PLGA film delivery system for a lipophilic drug. Int J Pharm. 2003. 252:1–9.
Article
37. Bonucci E, Ballanti P, Martelli A, Mereto E, Brambilla G, Bianco P, et al. Ipriflavone inhibits osteoclast differentiation in parathyroid transplanted parietal bone of rats. Calcif Tissue Int. 1992. 50:314–319.
Article
38. Cheng SL, Zhang SF, Nelson TL, Warlow PM, Civitelli R. Stimulation of human osteoblast differentiation and function by ipriflavone and its metabolites. Calcif Tissue Int. 1994. 55:356–362.
Article
39. Lee YS, Kim YJ, Lee KH, Hwang HS. Effects of ipriflavone on bone remodeling in the rat calvarial cell. Korean J Orthod. 2005. 35:275–285.
40. Lindhe J, Karring T, Araujo M. Lindhe J, Lang NP, Karring T, editors. The anatomy of periodontal tissues. Clinical Periodontology and Implant Dentistry. 2008. 5th ed. Oxford: Blackwell;27–31.
41. Maeder CL, Carnes DL, Graves DT. Alkaline phosphatase and osteocalcin levels in cells from periodontal explants. J Dent Res. 1988. 67:232. Abst. No. 958.
42. Piche JE, Carnes DL Jr, Graves DT. Initial characterization of cells derived from human periodontia. J Dent Res. 1989. 68:761–767.
Article
43. Roberts WE, Chase DC. Kinetics of cell proliferation and migration associated with orthodontically-induced osteogenesis. J Dent Res. 1981. 60:174–181.
Article
44. Basdra EK, Komposch G. Transmission and scanning electron microscopic analysis of mineralized loci formed by human periodontal ligament cells in vitro. J Orofac Orthop. 1999. 60:77–86.
Article